Xhale has numerous patents and patent applications, including issued and pending U.S. patents and foreign equivalents, related to the use of exhaled breath and novel vapor analysis for healthcare and medical purposes. The patent claims are broad, covering detection and measurement of various endogenous and exogenous compounds, various sensor platforms, multiple detection chemistries and use of Xhale’s breath-detection technology with nearly every approved drug. The patents include both broad device claims and specific methods claims, including using exhaled breath for determining the concentration of drugs and markers in exhaled breath, using markers and taggants to determining patient adherence in taking a medication, using breath for enzyme competency testing, breath-based correlation of blood concentration of therapeutic drugs, breath-based diagnostic testing for a wide variety of medical conditions and preventing the diversion of prescription drugs and minimizing drug counterfeiting via breath-detectible markers.
Xhale's intellectual property portfolio includes the following patents and applications: